Karius
Company

Last deal

$100M

Amount

Series C

Stage

02.05.2024

Date

3

all rounds

$354M

Total amount

date founded

Financing round

General

About Company
Karius provides genomic insights for infectious diseases to help clinicians make life-saving treatment decisions.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2014

Number of employees

Company Type

For Profit

Last funding type

Series C

IPO status

Private

Description

The company's non-invasive Karius Test maps a patient's microbial landscape from a single blood draw, using deep sequencing to detect minuscule traces of microbial DNA. The CLIA-certified and CAP-accredited laboratory develops molecular biology and data analysis tools to enable physicians to make rapid, hassle-free treatment decisions. Karius aims to eliminate infectious diseases as a major threat to human health by using genomics and AI to map patients' microbial landscapes.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
Sigenex

Sigenex

The company is developing a genetic testing lab that allows clinicians to make informed therapy decisions faster.

Sector

Medical Equipment and Services

Subsector

Medical Services

Keywords

Health Care, Biotechnology, Medical

Location

San Francisco, CA, USA
CapNostics

CapNostics

This company has developed a swallowable screening device for detecting Barrett's Esophagus and other upper GI diseases.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Location

Upper Black Eddy, PA 18972, USA

total rounds

1
Senseera

Senseera

Senseera develops liquid biopsy blood tests for early disease detection.

Sector

Medical Equipment and Services

Subsector

Medical Services

Keywords

Biotechnology, Health Care, Health Diagnostics

Location

Jerusalem, Israel
Lucence Health

Lucence Health

Lucence Health is a liquid biopsy company that detects cancer hallmarks for earlier detection and targeted treatment.

Sector

Medical Equipment and Services

Subsector

Medical Services

Location

Palo Alto, CA, USA

total rounds

2

total raised

$29.2M

Financials

Funding Rounds
7
3

Number of Funding Rounds

$354M

Money Raised

Their latest funding was raised on 02.05.2024. Their latest investor General Catalyst. Their latest round Series C

Date 
Funding Round 
Investors 
Money Raised 
Lead 
07.03.2022
2
20.01.2021
1
5AM Ventures

5AM Ventures

5AM Ventures is a venture capital firm that invests in early-stage companies in the life sciences industry.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Biotechnology, Financial Services

Location

Menlo Park, CA, USA

count Of Investments

154

count Of Exists

19
Gilde Healthcare

Gilde Healthcare

Gilde Healthcare is a European healthcare investor that specializes in lower mid-market buyouts and later stage venture.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Health Care, Venture Capital, Financial Services

Location

Utrecht, Netherlands

count Of Investments

87

count Of Exists

22
Khosla Ventures

Khosla Ventures

Khosla Ventures: venture capital firm advising entrepreneurs on breakthrough technologies.

Sector

General Industrials

Subsector

Diversified Industrials

Keywords

Biotechnology, Venture Capital, Financial Services

Location

Menlo Park, CA, USA

total rounds

1

total raised

$1.5M

count Of Investments

928

count Of Exists

131
Co-Investors
Investors
16
5

Number of lead investors

16

Number of investors

Investor 
Lead 
Round 
Partners 
No
Series B, Series C
Yes
Series C
General Catalyst

General Catalyst

General Catalyst is a venture capital firm that invests in early-stage and growth equity.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services, Finance

Location

Cambridge, MA, USA

count Of Investments

1013

count Of Exists

166

Blue Water Life Science Fund

Blue Water Life Science Fund is a venture capital firm focused on investing in early-stage companies in the life sciences industry.

Sector

Open End and Miscellaneous Investment Vehicles

Subsector

Open End and Miscellaneous Investment Vehicles

Location

Mill Valley, CA 94941, USA

count Of Investments

7
5AM Ventures

5AM Ventures

5AM Ventures is a venture capital firm that invests in early-stage companies in the life sciences industry.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Biotechnology, Financial Services

Location

Menlo Park, CA, USA

count Of Investments

154

count Of Exists

19

People

Founders
3
Steve Quake
Steve Quake

Steve Quake

Steve Quake is the Lee Otterson Professor in the School of Engineering and a professor of bioengineering of applied physics and physics at Stanford University. His group pioneered the development of microfluidic large-scale integration (mLSI). Prof. Quake made numerous contributions to the field of genomics, including the first single molecule DNA sequencing, techniques to perform single cell gene expression and genome sequencing, the development of non-invasive prenatal diagnostics, non-invasive tests for heart transplant rejection, and the development of approaches to sequence and analyze an individual's immune repertoire.

organization founded

1

Steve Quake

Tim Blauwkamp
Tim Blauwkamp

Tim Blauwkamp

current job

Karius
Karius

organization founded

1

Tim Blauwkamp

Mickey Kertesz
Mickey Kertesz

Mickey Kertesz

Kertesz co-founded Karius in 2014 to bring the pathogen detection technology he and colleagues developed at Stanford closer to the bedside. Prior to that, he was the CEO and co-founder of Moleculo, a long-reads DNA sequencing company, which was acquired by Illumina in late 2012. Dr. Kertesz earned an MS in computer science from Tel Aviv University and a PhD in computational biology from the Weizmann Institute of Science. He went on to complete his postdoctoral work in bioengineering at Stanford University, where he developed novel methods for investigating the genetic diversity of human viruses.

current job

Karius
Karius

organization founded

2

Mickey Kertesz

Employee Profiles
11
Steve Malaska

Steve Malaska

Chief Legal Officer

Rachel Jones

Rachel Jones

Chief Commercial Officer (CCO)

Alexander Ford

Alexander Ford

CEO

Mickey Kertesz

Mickey Kertesz

President, CPO & Co-Founder

William Ricketts

Senior Director & Clinical Development

Sivan Bercovici

Sivan Bercovici

CTO

Tim Blauwkamp

Tim Blauwkamp

Chief Scientific Officer, Co-Founder

Bill Quirk

Bill Quirk

Chief Financial Officer

Activity

Recent News
5
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range